209 related articles for article (PubMed ID: 32095613)
1. The importance of being parasiticidal… an update on drug development for the treatment of alveolar echinococcosis.
Lundström-Stadelmann B; Rufener R; Ritler D; Zurbriggen R; Hemphill A
Food Waterborne Parasitol; 2019 Jun; 15():e00040. PubMed ID: 32095613
[TBL] [Abstract][Full Text] [Related]
2. Repurposing of an old drug: In vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis.
Rufener R; Dick L; D'Ascoli L; Ritler D; Hizem A; Wells TNC; Hemphill A; Lundström-Stadelmann B
Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):440-450. PubMed ID: 30396011
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis.
Küster T; Stadelmann B; Hermann C; Scholl S; Keiser J; Hemphill A
Antimicrob Agents Chemother; 2011 Feb; 55(2):713-21. PubMed ID: 21135182
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the mechanism of action of mefloquine and derivatives against the parasite Echinococcus multilocularis.
Memedovski R; Preza M; Müller J; Kämpfer T; Rufener R; de Souza MVN; da Silva ET; de Andrade GF; Braga S; Uldry AC; Buchs N; Heller M; Lundström-Stadelmann B
Int J Parasitol Drugs Drug Resist; 2023 Apr; 21():114-124. PubMed ID: 36921443
[TBL] [Abstract][Full Text] [Related]
5. Establishment and application of unbiased in vitro drug screening assays for the identification of compounds against Echinococcus granulosus sensu stricto.
Kaethner M; Preza M; Kaempfer T; Zumstein P; Tamponi C; Varcasia A; Hemphill A; Brehm K; Lundström-Stadelmann B
PLoS Negl Trop Dis; 2023 Aug; 17(8):e0011343. PubMed ID: 37540716
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo efficacy of thiacloprid against Echinococcus multilocularis.
Liu C; Fan H; Ma J; Ma L; Ge RL
Parasit Vectors; 2021 Sep; 14(1):450. PubMed ID: 34488852
[TBL] [Abstract][Full Text] [Related]
7. Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis.
Rufener R; Ritler D; Zielinski J; Dick L; da Silva ET; da Silva Araujo A; Joekel DE; Czock D; Goepfert C; Moraes AM; de Souza MVN; Müller J; Mevissen M; Hemphill A; Lundström-Stadelmann B
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):331-340. PubMed ID: 29933218
[TBL] [Abstract][Full Text] [Related]
8. Targeting Echinococcus multilocularis PIM kinase for improving anti-parasitic chemotherapy.
Koike A; Becker F; Sennhenn P; Kim J; Zhang J; Hannus S; Brehm K
PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010483. PubMed ID: 36190997
[TBL] [Abstract][Full Text] [Related]
9. Metformin improves the therapeutic efficacy of low-dose albendazole against experimental alveolar echinococcosis.
Loos JA; Coccimiglio M; Nicolao MC; Rodrigues CR; Cumino AC
Parasitology; 2022 Jan; 149(1):138-144. PubMed ID: 35184788
[TBL] [Abstract][Full Text] [Related]
10. Oral Delivery of Anti-Parasitic Agent-Loaded PLGA Nanoparticles: Enhanced Liver Targeting and Improved Therapeutic Effect on Hepatic Alveolar Echinococcosis.
Li J; Yang Y; Han X; Li J; Tian M; Qi W; An H; Wu C; Zhang Y; Han S; Duan L; Wang W; Zhang W
Int J Nanomedicine; 2023; 18():3069-3085. PubMed ID: 37312930
[TBL] [Abstract][Full Text] [Related]
11. Suppressive effect of pseudolaric acid B on
Gao H; Huo L; Mo X; Jiang B; Luo Y; Xu B; Li J; Ma X; Jing T; Feng Z; Zhang T; Hu W
Front Microbiol; 2022; 13():1008274. PubMed ID: 36439797
[No Abstract] [Full Text] [Related]
12. In Vitro Activities of Dithiocarbamate Derivatives against
Kaethner M; Rennar G; Gallinger T; Kämpfer T; Hemphill A; Mäder P; Luque-Gómez A; Schlitzer M; Lundström-Stadelmann B
Trop Med Infect Dis; 2023 Dec; 8(12):. PubMed ID: 38133449
[TBL] [Abstract][Full Text] [Related]
13. Case Report: Amphotericin B and Mefloquine as a Salvage Treatment of Alveolar Echinococcosis.
Jelicic K; Papic N; Viskovic K; Vince A
Am J Trop Med Hyg; 2023 Mar; 108(3):581-583. PubMed ID: 36716742
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Asparagusic Acid against
Lu Z; Wang Y; Liu C; Fan H
Trop Med Infect Dis; 2024 May; 9(5):. PubMed ID: 38787043
[TBL] [Abstract][Full Text] [Related]
15. Data on the combined effect of atovaquone, mefloquine, and 3-bromopyruvic acid against
Kouguchi H; Enkai S; Matsuyama H; Hidaka M; Inaoka DK; Kita K; Yagi K
Data Brief; 2022 Dec; 45():108707. PubMed ID: 36426011
[TBL] [Abstract][Full Text] [Related]
16. Surgery versus conservative drug therapy in alveolar echinococcosis patients in Germany - A health-related quality of life comparison.
Schmidberger J; Steinbach J; Schlingeloff P; Kratzer W; Grüner B
Food Waterborne Parasitol; 2019 Sep; 16():e00057. PubMed ID: 32095627
[TBL] [Abstract][Full Text] [Related]
17. Regulation of hepatic microRNAs in response to early stage Echinococcus multilocularis egg infection in C57BL/6 mice.
Boubaker G; Strempel S; Hemphill A; Müller N; Wang J; Gottstein B; Spiliotis M
PLoS Negl Trop Dis; 2020 May; 14(5):e0007640. PubMed ID: 32442168
[TBL] [Abstract][Full Text] [Related]
18. Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis.
Lundström-Stadelmann B; Rufener R; Hemphill A
Int J Parasitol Drugs Drug Resist; 2020 Aug; 13():121-129. PubMed ID: 32636148
[TBL] [Abstract][Full Text] [Related]
19. Effect of sunitinib against Echinococcus multilocularis through inhibition of VEGFA-induced angiogenesis.
Jiang H; Wang X; Guo L; Tan X; Gui X; Liao Z; Li Z; Chen X; Wu X
Parasit Vectors; 2023 Nov; 16(1):407. PubMed ID: 37936208
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
